This study addresses the regulation of Staphylococcus aureus type 8 capsular polysaccharide (CP8) expression by the global regulators agr and sarA. We analyzed CP8 production, cap8-specific mRNA synthesis, and blaZ reporter gene activities of the transcriptional and translational fusions in strain Becker and its agr, sarA, and agr-sarA isogenic mutants during different phases of bacterial growth. In the wild-type strain, cap8 mRNA was undetectable until the mid-logarithmic phase of growth, whereas CP8 production was undetectable until 2 h later, at the onset of stationary phase. The delay most likely reflects the time needed for completing CP8 synthesis resulting from translation of cap8 mRNA. The agr mutation caused drastic reductions in CP8 production and cap8 gene transcription, suggesting that agr is a major positive regulator of CP8 expression. The results of gene fusion studies indicated that regulation by agr is exerted at the transcriptional level. In contrast, the sarA mutation caused only a slight reduction in cap8 mRNA synthesis and reporter gene activities. By comparing CP8 production and cap8 transcription, we observed that sarA affected CP8 production both trancriptionally and posttranslationally. We showed that agr was a major activator for cap gene expression not only in type 8 strain Becker but also in strains representing the four agr groups.More than 90% of Staphylococcus aureus strains produce capsular polysaccharide (CP). Eleven serotypes of staphylococcal CP have been identified, but only CP type 1 (CP1), CP2, CP5, and CP8 have been chemically characterized. CP1 and CP2 have been shown to be antiphagocytic virulence factors. Strains producing CP1 and CP2 are heavily encapsulated; however, these strains are rarely isolated clinically. In fact, more than 80% of clinical isolates produce either CP5 or CP8 (see reference 23 for a review). Recently, CP5 has been shown to play an important role in the pathogenesis of S. aureus, most probably by allowing the organism to resist uptake and killing by phagocytes (1,27,43). Because of their prevalence, CP5 and CP8 have been used as targets for vaccine development, and specific antibodies against CP5 and CP8 have been shown to be protective against S. aureus infections (13, 24).The cap1, cap5, and cap8 gene clusters, required for the synthesis of CP1, CP5, and CP8, respectively, have been cloned and sequenced. The cap5 and cap8 operons are allelic, whereas the cap1 locus is located at a different location. Twelve of the 16 genes in the cap5 and cap8 operons have high degrees of similarity, which reflects the fact that the repeating units of CP5 and CP8 are almost identical (23). Transcriptional analyses have shown that all 16 genes of the cap8 locus are transcribed as a large transcript from a major promoter upstream of the first gene, cap8A. Although several internal promoters within the cap8 gene cluster have also been identified by genetic complementation and reporter gene fusion studies, these internal promoters are much weaker than the primary pro...